Testing effectiveness (Phase 2)Study completedNCT00116597
What this trial is testing
Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma
Who this might be right for
Melanoma
University Hospital, Basel, Switzerland 15